nDivision Inc.

$ Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000147793222002301 Filed on April 14, 2022

Income Statement

Concept	2021 Q4	2021	2020 Q4

Balance Sheet

Concept	2021 Q4	2021	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$521.0K	$521.0K	$1.807M
YoY Change	-71.16%	-71.16%	2.78%
Cash & Equivalents	$521.0K		$1.807M
Short-Term Investments
Other Short-Term Assets	$163.1K	$163.1K	$121.3K
YoY Change	34.41%	34.41%	12.95%
Inventory
Prepaid Expenses	$163.1K		$121.3K
Receivables	$572.0K	$572.0K	$531.2K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$1.256M	$1.256M	$2.459M
YoY Change	-48.92%	-48.92%	1.87%
LONG-TERM ASSETS
Property, Plant & Equipment	$418.6K	$755.8K	$540.9K
YoY Change	-22.61%	-23.1%	-28.16%
Goodwill
YoY Change
Intangibles	$0.00		$455.3K
YoY Change	-100.0%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$755.8K	$755.8K	$1.438M
YoY Change	-47.45%	-47.45%	1.94%
TOTAL ASSETS
Total Short-Term Assets	$1.256M	$1.256M	$2.459M
Total Long-Term Assets	$755.8K	$755.8K	$1.438M
Total Assets	$2.012M	$2.012M	$3.897M
YoY Change	-48.38%	-48.38%	1.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$233.2K	$233.2K	$153.4K
YoY Change	52.01%	52.0%	11.52%
Accrued Expenses	$812.2K	$941.6K	$373.5K
YoY Change	117.46%	96.53%	-38.12%
Deferred Revenue
YoY Change
Short-Term Debt	$331.9K	$331.9K	$514.7K
YoY Change	-35.52%	-35.52%
Long-Term Debt Due	$0.00	$968.2K	$18.10K
YoY Change	-100.0%	671.79%	-86.02%
Total Short-Term Liabilities	$2.780M	$2.780M	$2.161M
YoY Change	28.66%	28.66%	-25.64%
LONG-TERM LIABILITIES
Long-Term Debt	$646.7K	$646.7K	$1.310M
YoY Change	-50.65%	-50.65%	3044.49%
Other Long-Term Liabilities	$226.9K	$226.9K	$336.5K
YoY Change	-32.59%	-32.59%	-18.38%
Total Long-Term Liabilities	$873.5K	$873.5K	$1.647M
YoY Change	-46.96%	-46.96%	262.76%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.780M	$2.780M	$2.161M
Total Long-Term Liabilities	$873.5K	$873.5K	$1.647M
Total Liabilities	$3.654M	$3.654M	$3.808M
YoY Change	-4.04%	-4.04%	13.33%
SHAREHOLDERS EQUITY
Retained Earnings	-$11.18M		-$7.113M
YoY Change	57.16%
Common Stock	$44.92K		$42.50K
YoY Change	5.69%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$1.642M	-$1.642M	$89.59K
YoY Change
Total Liabilities & Shareholders Equity	$2.012M	$2.012M	$3.897M
YoY Change	-48.38%	-48.38%	1.9%

Cashflow Statement

Concept	2021 Q4	2021	2020 Q4

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	136220	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1806606	USD
CY2021Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	418635	USD
CY2021Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	229327	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	129392	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	105615	USD
CY2020Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	125449	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2780355	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2160942	USD
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	163087	USD
CY2021	dei	Auditor Location AuditorLocation	Marlton, New Jersey
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	521039	USD
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	40000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	26000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	571994	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	531244	USD
CY2020Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	121339	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	1256120	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	2459189	USD
CY2020Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	540918	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	0	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	455320	USD
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	337179	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	9492125	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-11178993	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-1641948	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	153427	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3897367	USD
CY2020Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	441940	USD
CY2021Q4	us-gaap	Other Assets OtherAssets	337179	USD
CY2020Q4	us-gaap	Other Assets OtherAssets	897260	USD
CY2021Q4	us-gaap	Assets Assets	2011934	USD
CY2020Q4	us-gaap	Assets Assets	3897367	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	233217	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	888325	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	373487	USD
CY2020Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	870184	USD
CY2021Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	213606	USD
CY2020Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	0	USD
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	118277	USD
CY2020Q4	us-gaap	Notes Payable Current NotesPayableCurrent	514678	USD
CY2021Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	831991	USD
CY2020Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	0	USD
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	18102	USD
CY2021Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	0	USD
CY2020Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	195822	USD
CY2021Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	358770	USD
CY2020Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	734282	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	226846	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	336520	USD
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	287911	USD
CY2020Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	380209	USD
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	873527	USD
CY2020Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1646833	USD
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	180000000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	44919870	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	42499783	shares
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	44920	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	42500	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	7160175	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-7113083	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	89592	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2011934	USD
CY2021	us-gaap	Revenues Revenues	6143273	USD
CY2020	us-gaap	Revenues Revenues	5927173	USD
CY2021	ndvn	Service Costs ServiceCosts	5338979	USD
CY2020	ndvn	Service Costs ServiceCosts	4107556	USD
CY2021	us-gaap	Gross Profit GrossProfit	804294	USD
CY2020	us-gaap	Gross Profit GrossProfit	1819617	USD
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4573674	USD
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3217188	USD
CY2021	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	302115	USD
CY2020	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	USD
CY2021	us-gaap	Operating Expenses OperatingExpenses	4875789	USD
CY2020	us-gaap	Operating Expenses OperatingExpenses	3217188	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-4071495	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-1397571	USD
CY2021	us-gaap	Interest Expense InterestExpense	717760	USD
CY2020	us-gaap	Interest Expense InterestExpense	109810	USD
CY2021	ndvn	Non Cash Lease Expense NonCashLeaseExpense	104761	USD
CY2020	ndvn	Non Cash Lease Expense NonCashLeaseExpense	101035	USD
CY2020	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	96787	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-1498926	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	89592	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions	936926	USD
CY2021	ndvn	Common Stock Issued For Commitment Fee Amount CommonStockIssuedForCommitmentFeeAmount	177600	USD
CY2021	ndvn	Warrant Issued With Debt WarrantIssuedWithDebt	34050	USD
CY2021	ndvn	Beneficial Conversion Feature BeneficialConversionFeature	1025375	USD
CY2021	ndvn	Exercise Of Stock Options Cashless Amount ExerciseOfStockOptionsCashlessAmount	0	USD
CY2021	ndvn	Conversion Of Notes Payable And Accrued Interest Net Of Unamortized Discount Amount ConversionOfNotesPayableAndAccruedInterestNetOfUnamortizedDiscountAmount	160419	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-4065910	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-1641948	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-4065910	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-1498926	USD
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	331663	USD
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	432278	USD
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	14000	USD
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	24624	USD
CY2021	us-gaap	Debt Instrument Convertible Beneficial Conversion Feature DebtInstrumentConvertibleBeneficialConversionFeature	447381	USD
CY2020	us-gaap	Debt Instrument Convertible Beneficial Conversion Feature DebtInstrumentConvertibleBeneficialConversionFeature	20582	USD
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	19327	USD
CY2020	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	USD
CY2021	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	6363	USD
CY2020	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	0	USD
CY2021	ndvn	Ppp Loan Forgiveness PppLoanForgiveness	716982	USD
CY2020	ndvn	Ppp Loan Forgiveness PppLoanForgiveness	0	USD
CY2021	us-gaap	Other Income OtherIncome	0	USD
CY2020	us-gaap	Other Income OtherIncome	8455	USD
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	5585	USD
CY2020	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-101355	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4065910	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1498926	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-4065910	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-1498926	USD
CY2021	ndvn	Earnings Per Share Basic And Diluted1 EarningsPerShareBasicAndDiluted1	-0.09
CY2020	ndvn	Earnings Per Share Basic And Diluted1 EarningsPerShareBasicAndDiluted1	-0.04
CY2021	ndvn	Weighted Average Number Of Share Outstanding Basic And Diluted1 WeightedAverageNumberOfShareOutstandingBasicAndDiluted1	43232248	shares
CY2020	ndvn	Weighted Average Number Of Share Outstanding Basic And Diluted1 WeightedAverageNumberOfShareOutstandingBasicAndDiluted1	41437625	shares
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	464860	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions	690571	USD
CY2020	ndvn	Beneficial Conversion Feature BeneficialConversionFeature	336300	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	936926	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	787358	USD
CY2021	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	0	USD
CY2020	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	88	USD
CY2021	ndvn	Gain On The Change In Derivative Liability GainOnTheChangeInDerivativeLiability	-6363	USD
CY2020	ndvn	Gain On The Change In Derivative Liability GainOnTheChangeInDerivativeLiability	0	USD
CY2021	ndvn	Forgiveness Of Sba Ppp Loan ForgivenessOfSbaPppLoan	-716982	USD
CY2020	ndvn	Forgiveness Of Sba Ppp Loan ForgivenessOfSbaPppLoan	0	USD
CY2021	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	302115	USD
CY2020	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-7043	USD
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-41748	USD
CY2020	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-13911	USD
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-54750	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	79790	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-89749	USD
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	327675	USD
CY2021	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-640857	USD
CY2020	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-1107641	USD
CY2021	ndvn	Increase Decrease In Operating Lease Payable IncreaseDecreaseInOperatingLeasePayable	85897	USD
CY2020	ndvn	Increase Decrease In Operating Lease Payable IncreaseDecreaseInOperatingLeasePayable	94619	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3048869	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1445924	USD
CY2021	us-gaap	Repayments Of Debt RepaymentsOfDebt	18102	USD
CY2020	us-gaap	Repayments Of Debt RepaymentsOfDebt	54056	USD
CY2021	us-gaap	Proceeds From Sale Of Flight Equipment ProceedsFromSaleOfFlightEquipment	0	USD
CY2020	us-gaap	Proceeds From Sale Of Flight Equipment ProceedsFromSaleOfFlightEquipment	401	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3892	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	11064	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-21994	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-64719	USD
CY2021	ndvn	Proceeds Of Paycheck Protection Note Payable ProceedsOfPaycheckProtectionNotePayable	0	USD
CY2020	ndvn	Proceeds Of Paycheck Protection Note Payable ProceedsOfPaycheckProtectionNotePayable	710500	USD
CY2021	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	213606	USD
CY2020	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	USD
CY2021	us-gaap	Proceeds From Loan Originations1 ProceedsFromLoanOriginations1	515500	USD
CY2021	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	1190000	USD
CY2020	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	1050000	USD
CY2021	ndvn	Repayment Of Finance Lease Obligations RepaymentOfFinanceLeaseObligations	-133810	USD
CY2020	ndvn	Repayment Of Finance Lease Obligations RepaymentOfFinanceLeaseObligations	-200946	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1785296	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1559554	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1285567	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	48911	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1806606	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1757695	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	521039	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1806606	USD
CY2021	us-gaap	Interest Paid Net InterestPaidNet	40473	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	33318	USD
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	USD
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	34000	USD
CY2021	ndvn	Conversion Of Notes Payable And Accrued Interest To Common Stock Net Of Unamortized Discount ConversionOfNotesPayableAndAccruedInterestToCommonStockNetOfUnamortizedDiscount	160419	USD
CY2020	ndvn	Conversion Of Notes Payable And Accrued Interest To Common Stock Net Of Unamortized Discount ConversionOfNotesPayableAndAccruedInterestToCommonStockNetOfUnamortizedDiscount	0	USD
CY2021	ndvn	Purchase Of Equipment Under Capital Lease PurchaseOfEquipmentUnderCapitalLease	51396	USD
CY2020	ndvn	Purchase Of Equipment Under Capital Lease PurchaseOfEquipmentUnderCapitalLease	550066	USD
CY2021	ndvn	Amortization Of Beneficial Conversion Feature AmortizationOfBeneficialConversionFeature	1025375	USD
CY2020	ndvn	Amortization Of Beneficial Conversion Feature AmortizationOfBeneficialConversionFeature	336300	USD
CY2020	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	USD
CY2021	us-gaap	Payments For Commissions PaymentsForCommissions	177600	USD
CY2020	us-gaap	Payments For Commissions PaymentsForCommissions	0	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	34050	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	0	USD
CY2021	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	1705500	USD
CY2021Q4	ndvn	Working Capital WorkingCapital	1524235	USD
CY2021	us-gaap	Gain Loss On Sale Of Accounts Receivable GainLossOnSaleOfAccountsReceivable	90000	USD
CY2021	ndvn	Invoices Peoceeds InvoicesPeoceeds	231175	USD
CY2021	ndvn	Received Advance ReceivedAdvance	213606	USD
CY2021	ndvn	Fee Related Factoring Agreement FeeRelatedFactoringAgreement	10600	USD
CY2021	ndvn	Description Of Factored Receivables DescriptionOfFactoredReceivables	The Company receives 90% of the factored receivables for a fee of 2.4% of the factored invoice and has committed to a minimum balance of $150,000 of invoices factored for six months from the initial funding in November 2021
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Management uses estimates and assumptions in preparing these consolidated financial statements. Those estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities, and the reported revenues and expenses. Actual results could differ from those estimates.</p>
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	40000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	26000	USD
CY2021	us-gaap	Marketing Expense MarketingExpense	456466	USD
CY2020	us-gaap	Marketing Expense MarketingExpense	56943	USD
CY2021	ndvn	Impairment Related To Purchased Of Contracts ImpairmentRelatedToPurchasedOfContracts	302115	USD
CY2021	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Financial instruments, which potentially subject the Company to concentrations of credit risk, are cash and accounts receivable. See Note 15 for significant customer concentration disclosure.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Cash is maintained with a major financial institution in the United States and may exceed the amount of insurance provided on such deposits. Generally, these deposits may be redeemed upon demand, and, therefore, bear minimal risk. At December 31, 2021 and 2020, deposits in excess of FDIC limits were $271,039 and $1,556,606, respectively.</p>
CY2021	ndvn	Deposits In Excess Of Fdic Limits DepositsInExcessOfFdicLimits	271039	USD
CY2020	ndvn	Deposits In Excess Of Fdic Limits DepositsInExcessOfFdicLimits	1556606	USD
CY2021	ndvn	Convertible Debt And Securities ConvertibleDebtAndSecurities	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Company follows beneficial conversion feature guidance in ASC 470-20, which applies to convertible stock as well as convertible debt. A beneficial conversion feature is defined as a nondetachable conversion feature that is in the money at the commitment date. The beneficial conversion feature guidance requires recognition of the conversion option's in-the-money portion, the intrinsic value of the option, in equity, with an offsetting reduction to the carrying amount of the instrument. The resulting discount is amortized as interest over the life of the instrument, if a stated maturity date exists, or to the earliest conversion date, if there is no stated maturity date. If the earliest conversion date is immediately upon issuance, the expense must be recognized at inception. When there is a subsequent change to the conversion ratio based on a future occurrence, the new conversion price may trigger the recognition of an additional beneficial conversion feature on occurrence.</p>
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1958216	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1902041	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1539581	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1361123	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	418635	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	540918	USD
CY2021	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	178458	USD
CY2020	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	58157	USD
CY2021	us-gaap	Adjustment For Amortization AdjustmentForAmortization	154088	USD
CY2020	us-gaap	Adjustment For Amortization AdjustmentForAmortization	171570	USD
CY2020	ndvn	Equipment And Software Disposed EquipmentAndSoftwareDisposed	16105	USD
CY2020	ndvn	Related Accumulated Depreciation RelatedAccumulatedDepreciation	15792	USD
CY2020	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	401	USD
CY2020	ndvn	Gain On Disposed Of Assets GainOnDisposedOfAssets	88	USD
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	153205	USD
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	202551	USD
CY2021Q4	ndvn	Accumulated Impairment AccumulatedImpairment	302115	USD
CY2020Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	138707	USD
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	144773	USD
CY2020Q4	us-gaap	Interest Payable Current InterestPayableCurrent	23185	USD
CY2021Q4	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	5810	USD
CY2020Q4	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	23525	USD
CY2021Q4	ndvn	Accrued Franchise Tax AccruedFranchiseTax	14862	USD
CY2020Q4	ndvn	Accrued Franchise Tax AccruedFranchiseTax	11832	USD
CY2021Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	76137	USD
CY2020Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	0	USD
CY2021Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	459209	USD
CY2020Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	176238	USD
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	888325	USD
CY2020Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	373487	USD
CY2021Q4	us-gaap	Administrative Fees Description AdministrativeFeesDescription	The agreement provides for an advanced rate of 90% with a fee of 2.4% to be charged on the gross face amount of the invoices purchased for 30 days
CY2021Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.40
CY2021	ndvn	Commitment Fee CommitmentFee	150000	USD
CY2021	ndvn	Commitmentfee Additional CommitmentfeeAdditional	150000	USD
CY2021	ndvn	Aggregate Cash Proceeds AggregateCashProceeds	515500	USD
CY2021	ndvn	Broker Fees BrokerFees	12000	USD
CY2021	ndvn	Commitment Fee Maximum CommitmentFeeMaximum	1000000	USD
CY2021	ndvn	Commitment Fee Minimum CommitmentFeeMinimum	150000	USD
CY2021	ndvn	Gross Offering Proceeds GrossOfferingProceeds	5000000	USD
CY2021Q4	us-gaap	Convertible Debt ConvertibleDebt	450000	USD
CY2021Q4	ndvn	Convertible Note Accrued Interest ConvertibleNoteAccruedInterest	3994	USD
CY2021	ndvn	Convertible Of Common Stock Shares ConvertibleOfCommonStockShares	1134984	shares
CY2021	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	293575	USD
CY2021	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	1790000	USD
CY2020	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	1050000	USD
CY2020	ndvn	Amortization Of Debt Discount AmortizationOfDebtDiscount	315718	USD
CY2021	ndvn	Convertible Debt Net Of Debt Discount ConvertibleDebtNetOfDebtDiscount	1190761	USD
CY2020	ndvn	Convertible Debt Net Of Debt Discount ConvertibleDebtNetOfDebtDiscount	734282	USD
CY2021	ndvn	Short Term Convertible Debt Net Of Debt Discount ShortTermConvertibleDebtNetOfDebtDiscount	831991	USD
CY2020	ndvn	Short Term Convertible Debt Net Of Debt Discount ShortTermConvertibleDebtNetOfDebtDiscount	0	USD
CY2021	ndvn	Long Term Convertible Debt Net Of Debt Discount LongTermConvertibleDebtNetOfDebtDiscount	358770	USD
CY2020	ndvn	Long Term Convertible Debt Net Of Debt Discount LongTermConvertibleDebtNetOfDebtDiscount	734282	USD
CY2021Q4	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	164967	USD
CY2021Q4	us-gaap	Capital Leases Future Minimum Payments Due In Three Years CapitalLeasesFutureMinimumPaymentsDueInThreeYears	145383	USD
CY2021Q4	us-gaap	Capital Leases Future Minimum Payments Due In Four Years CapitalLeasesFutureMinimumPaymentsDueInFourYears	126320	USD
CY2021Q4	us-gaap	Capital Leases Future Minimum Payments Due In Five Years CapitalLeasesFutureMinimumPaymentsDueInFiveYears	43970	USD
CY2021Q4	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	480640	USD
CY2021Q4	us-gaap	Capital Leases Future Minimum Payments Interest Included In Payments CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments	56509	USD
CY2021Q4	us-gaap	Capital Lease Obligations CapitalLeaseObligations	424131	USD
CY2021Q4	us-gaap	Short Term Lease Commitment Amount ShortTermLeaseCommitmentAmount	136220	USD
CY2021Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	287911	USD
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	133806	USD
CY2020	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	194478	USD
CY2021Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets	406358	USD
CY2020Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets	509050	USD
CY2021Q4	us-gaap	Other Commitment Due In Second Year OtherCommitmentDueInSecondYear	129392	USD
CY2021Q4	us-gaap	Other Commitment Due In Third Year OtherCommitmentDueInThirdYear	131859	USD
CY2021	ndvn	Schedule Of Weighted Average Remaining Lease Term And Discount Rate For Operating Leases ScheduleOfWeightedAverageRemainingLeaseTermAndDiscountRateForOperatingLeases	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Weighted average remaining lease term</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:right;">35 Months</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Weighted average incremental borrowing rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5.0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr></tbody></table>
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.050	pure
CY2021Q4	us-gaap	Other Commitment Due In Fourth Year OtherCommitmentDueInFourthYear	120871	USD
CY2021Q4	us-gaap	Other Commitment OtherCommitment	382122	USD
CY2021Q4	ndvn	Less Imputed Interest LessImputedInterest	-25884	USD
CY2021Q4	us-gaap	Other Commitments Future Minimum Payments Remainder Of Fiscal Year OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear	356238	USD
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	105615	USD
CY2021	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	136311	USD
CY2021	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	36177	USD
CY2021	us-gaap	Lease Cost LeaseCost	172488	USD
CY2021	us-gaap	Stock Issued During Period Shares Employee Benefit Plan StockIssuedDuringPeriodSharesEmployeeBenefitPlan	8526544	shares
CY2021	ndvn	Options Granted Not Part Of A Shareholder Approved Plan OptionsGrantedNotPartOfAShareholderApprovedPlan	700000	shares
CY2021	ndvn	Option Outstanding OptionOutstanding	9226544	shares
CY2021Q2	ndvn	Description Of Stock Option Of Shares DescriptionOfStockOptionOfShares	stock option plan that increases the available options from 8,000,000 shares to 18,000,000 shares, which was approved majority written consent of the shareholders
CY2020Q4	ndvn	Number Of Options Outstanding Begining Balance NumberOfOptionsOutstandingBeginingBalance	9601677	USD
CY2019Q4	ndvn	Number Of Options Outstanding Begining Balance NumberOfOptionsOutstandingBeginingBalance	6939178	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2200000	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2825000	shares
CY2021	ndvn	Exercised Converted ExercisedConverted	-175000	shares
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	2400133	shares
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	162501	shares
CY2021Q4	ndvn	Number Of Options Outstanding Ending Balance NumberOfOptionsOutstandingEndingBalance	9226544	shares
CY2020Q4	ndvn	Number Of Options Outstanding Ending Balance NumberOfOptionsOutstandingEndingBalance	9601677	shares
CY2021	ndvn	Number Of Options Exercisable At End Of Period NumberOfOptionsExercisableAtEndOfPeriod	7223766	shares
CY2020	ndvn	Number Of Options Exercisable At End Of Period NumberOfOptionsExercisableAtEndOfPeriod	6513572	shares
CY2021	ndvn	Number Of Options Available For Grant At End Of Period NumberOfOptionsAvailableForGrantAtEndOfPeriod	2002778	shares
CY2020	ndvn	Number Of Options Available For Grant At End Of Period NumberOfOptionsAvailableForGrantAtEndOfPeriod	598323	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.47
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.30
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.38
CY2021	ndvn	Terminated During The Period TerminatedDuringThePeriod	0.35
CY2020	ndvn	Terminated During The Period TerminatedDuringThePeriod	0.60
CY2021	ndvn	Outstanding At End Of The Period OutstandingAtEndOfThePeriod	0.41
CY2020	ndvn	Outstanding At End Of The Period OutstandingAtEndOfThePeriod	0.39
CY2021	ndvn	Exercisable At End Of Period ExercisableAtEndOfPeriod	0.41
CY2020	ndvn	Exercisable At End Of Period ExercisableAtEndOfPeriod	0.40
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	936926	USD
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	927273	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P5Y
CY2021	us-gaap	Common Stock Dividends Shares CommonStockDividendsShares	85103	shares
CY2021Q4	us-gaap	Cash Cash	175000	USD
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y6M
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P7Y6M
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0207	pure
CY2020Q4	ndvn	Number Of Warrant Outstanding Begining Balance NumberOfWarrantOutstandingBeginingBalance	872752	USD
CY2019Q4	ndvn	Number Of Warrant Outstanding Begining Balance NumberOfWarrantOutstandingBeginingBalance	122752	USD
CY2021	ndvn	Share Based Compensation Arrangement By Share Based Payment Award Warrant Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantGrantsInPeriodGross	500000	shares
CY2020	ndvn	Share Based Compensation Arrangement By Share Based Payment Award Warrant Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantGrantsInPeriodGross	750000	shares
CY2021Q4	ndvn	Number Of Warrant Outstanding Ending Balance NumberOfWarrantOutstandingEndingBalance	1372752	shares
CY2020Q4	ndvn	Number Of Warrant Outstanding Ending Balance NumberOfWarrantOutstandingEndingBalance	872752	shares
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	USD
CY2021	us-gaap	Principal Transactions Revenue PrincipalTransactionsRevenue	450000	USD
CY2021	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	1134984	shares
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	293575	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	276316	USD
CY2021	us-gaap	Related Party Costs RelatedPartyCosts	90000	USD
CY2020	us-gaap	Related Party Costs RelatedPartyCosts	72500	USD
CY2021	ndvn	Schedule Of Customer Accounts Receivable Concentration ScheduleOfCustomerAccountsReceivableConcentration	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2020</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Customer A</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">92</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">80</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Customer E</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">14</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr></tbody></table>
CY2020Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	17358	USD
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	2856429	USD
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	1710998	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2856429	USD
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	7526	USD
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	806	USD
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	2886865	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1728356	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	30436	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	17358	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	30436	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1710998	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	0	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	10693683	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	USD
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2021	ndvn	Total Income Tax Expense Benefit TotalIncomeTaxExpenseBenefit	0	USD
CY2020	ndvn	Total Income Tax Expense Benefit TotalIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-1145431	USD
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-439687	USD
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	0	USD
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	0	USD
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1145431	USD
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	439687	USD
CY2021	us-gaap	Income Tax Expense Benefit Intraperiod Tax Allocation IncomeTaxExpenseBenefitIntraperiodTaxAllocation	0	USD
CY2020	us-gaap	Income Tax Expense Benefit Intraperiod Tax Allocation IncomeTaxExpenseBenefitIntraperiodTaxAllocation	0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	2245673	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1391824	USD
CY2021Q4	ndvn	Stock Options StockOptions	532669	USD
CY2020Q4	ndvn	Stock Options StockOptions	335726	USD
CY2021Q4	ndvn	Amortization And Impairment AmortizationAndImpairment	100997	USD
CY2020Q4	ndvn	Amortization And Impairment AmortizationAndImpairment	0	USD

Files In Submission

Name	View Source	Status
0001477932-22-002301-index-headers.html	Edgar Link	pending
0001477932-22-002301-index.html	Edgar Link	pending
0001477932-22-002301.txt	Edgar Link	pending
0001477932-22-002301-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
ndvn-20211231.xsd	Edgar Link	pending
ndvn-20211231_cal.xml	Edgar Link	unprocessable
ndvn-20211231_def.xml	Edgar Link	unprocessable
ndvn-20211231_lab.xml	Edgar Link	unprocessable
ndvn-20211231_pre.xml	Edgar Link	unprocessable
ndvn_10k.htm	Edgar Link	pending
ndvn_10k_htm.xml	Edgar Link	completed
ndvn_ex231.htm	Edgar Link	pending
ndvn_ex311.htm	Edgar Link	pending
ndvn_ex312.htm	Edgar Link	pending
ndvn_ex321.htm	Edgar Link	pending
ndvn_ex322.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

nDivision Inc.

2021 Q4 Form 10-K Financial Statement

#000147793222002301 Filed on April 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission